News

Gaudium IVF shares list at 5% premium over issue priceThe IPO of Gaudium IVF and Women Health was subscribed 7.27 times at close, driven by sustained demand from retail and non-institutional investors.By Meghna Sen  February 27, 2026, 10:00:27 AM IST (Published)2 Min ReadShares of fertility services provider Gaudium IVF and Women Health made a moderate debut on the bourses on Friday, February 27. The stock opened at ₹83 on both the NSE and BSE, a premium of 5.06% over its issue price of ₹79.

Ahead of the listing, shares of the New Delhi-based company were trading flat in the grey market.

Mahesh M Ojha of Kantilal Chhaganlal Securities said IPO-allotted investors with a medium- to long-term horizon can continue to hold the stock.

Short-term investors, however, may consider booking partial listing gains, if available.

The IPO of Gaudium IVF and Women Health was subscribed 7.27 times at close, driven by sustained demand from retail and non-institutional investors.

The retail individual investors portion was subscribed 7.60 times, while the non-institutional investor segment saw strong traction with 14.05 times subscription. The qualified institutional buyer portion was subscribed 1.62 times.

Gaudium IVF's ₹165-crore book-built issue comprised a fresh issue of shares worth ₹90 crore and an offer for sale of ₹75 crore by promoter and founder Dr Manika Khanna.

The price band for the issue was fixed at ₹75-79 per share.

Ahead of the public issue, the company raised ₹49.5 crore from four anchor investors on February 19, allocating 62.65 lakh shares at the upper end of the price band.

Meru Investment Fund was the largest anchor investor, investing nearly ₹17 crore, followed by Sanshi Fund with an investment of about ₹12.5 crore. Hornbill Orchid India Fund and Carnelian India Multi-Strategy Fund invested ₹10 crore each.

Incorporated in 2015, the New Delhi-based fertility services provider operates under a hub-and-spoke model, with seven hubs across key markets including Delhi, Mumbai, Punjab, Jammu and Kashmir, Bihar and Bengaluru.

These are supported by 28 spoke centres through strategic alliances with infertility specialists.

The company plans to utilise ₹50 crore from the fresh issue proceeds to establish 19 new IVF centres, ₹20 crore to repay certain outstanding loans, and the remaining funds for general corporate purposes.Continue ReadingNote To ReadersDisclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.TagsIPO